Apotex Recalls Duloxetine Capsules Due to Dissolution Failure
Apotex Scientific is recalling Duloxetine Delayed-Release Capsules because stability testing revealed out-of-specification dissolution results.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences, fitting the 'Low' severity criteria for documentation or minor quality issues.
Plain-English summary
Apotex Scientific, Inc. is recalling Duloxetine Delayed-Release Capsules, USP, 30 mg, 30-count bottles. The recall involves specific lots (KY5120, KW2164, KY9953, KV9791, KV9792) with an expiration date of 03/31/2016. The product was distributed nationwide, including Alaska, Hawaii, and Puerto Rico.
The recall was initiated because the product failed to meet dissolution specifications during stability testing. Dissolution is a critical quality attribute that ensures the medication releases the active ingredient at the correct rate for the body to absorb it properly. Out-of-specification results indicate that the product may not perform as intended.
Consumers and healthcare providers should stop using the affected bottles and return them to the pharmacy or point of purchase for a refund or replacement. Patients should consult their healthcare provider for alternative treatment options if necessary.
The recalled product
- Product
- Duloxetine Delayed-Release Capsules, USP, 30 mg, 30-count bottles, Rx only, Manufactured by Apotex Inc, Toronto, Ontario M9L 1T9, Manufactured for Apotex Corp. Weston Florida 33326, NDC 60505-2996-3; UPC # 360505299638.
- Manufacturer
- Apotex Scientific, Inc
- Category
- Drug — Prescription Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: KY5120
- KW2164
- KY9953
- KV9791
- KV9792
- Exp 03/31/2016.
Distribution
Part of a larger recall action
This product is one of 3 recalled by Apotex Scientific, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Apotex Scientific, Inc
See all →- ModerateApotex Recalls Duloxetine Capsules Due to Dissolution Failure
FDA (Drugs) · 2016-07-20
- LowApotex Recalls Duloxetine Capsules Due to Failed Dissolution Testing
FDA (Drugs) · 2016-07-20
Same hazard · dissolution failure
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateMylan Recalls Acamprosate Calcium Tablets Due to Dissolution Failure
FDA (Drugs) · 2026-08-26
- ModerateChlorthalidone 25mg tablets failed dissolution specifications in two batches
FDA (Drugs) · 2026-06-24
- ModerateNiacin extended-release tablets failed dissolution testing at 24 hours
FDA (Drugs) · 2026-06-17
- ModerateMinocycline extended-release tablets failed dissolution testing during stability analysis
FDA (Drugs) · 2026-06-17